MPP Association letter to European Commission on MDR/IVDR targeted assessment
In the context of the anticipated targeted assessment of the Medical Devices and In Vitro Diagnostics Regulations (MDR & IVDR), the MPP Association shared a letter with the European Commission to present MPP priorities. This letter presents key aspects on which...
MPP publishes position paper on impact of IVDR on use of in-house devices in clinical trials
The Medtech & Pharma Platform Association (MPP) is pleased to announce the publication of a paper entitled ‘Impact of the IVDR on the use of in-house devices by health institutions and central laboratories in clinical trials’. In this position paper, the MPP...
11th edition of the Medtech & Pharma Platform Association annual conference
21 October 2024 – Press release The 11th Medtech & Pharma Platform Association (MPP) Annual Conference (MPP 2024) was held on 3 September 2024, in Basel, Switzerland. The theme of this year’s conference was “Combined products of tomorrow – Developing...
The 11th edition of the Medtech & Pharma Platform Association annual conference kicks-off in Basel
3 September 2024 – Press release Today, the MPP Annual Conference, themed “Combined products of tomorrow – developing solutions for and with patients”, is taking place at the Novartis Campus in Basel, Switzerland. Shayesteh Fürst-Ladani, MPP President, and Mike...
